Amylin deposition contributes to insulin resistance and oxidative stress being responsible for the development of type II diabetes mellitus (T2DM) by forming toxic amyloid aggregates leading to β-cell mass loss and subsequent reduction in insulin secretion. This evidence concerns the gene INS and type 2 diabetes mellitus.